Typhoid Antibody Testing Market Report 2024

The typhoid antibody testing market size has grown strongly in recent years. It will grow from $7.27 billion in 2023 to $7.83 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including increased collaborative efforts aimed at developing new testing tools, economic growth in developing countries, rising competition among market players, the availability of cost-effective diagnostic kits, and supportive government initiatives.

The typhoid antibody testing market size is expected to see strong growth in the next few years. It will grow to $10.61 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The projected growth is driven by rising disease prevalence, increasing morbidity and mortality rates, heightened demand for travel-related testing, expanding healthcare expenditures, and heightened awareness of typhoid fever among healthcare professionals and the general population. Key trends anticipated during the forecast period encompass advancements in technology, global health campaigns, a focus on outbreak readiness and surveillance, ongoing efforts in developing new typhoid antibody tests, and an increase in healthcare investment.

The anticipated increase in waterborne diseases is expected to drive the expansion of the typhoid antibody testing market in the future. Waterborne diseases are caused by pathogenic microorganisms that are transmitted through contaminated water sources. Factors contributing to the rise in these diseases include inadequate sanitation and hygiene practices, limited access to clean drinking water, rapid urbanization, climate variability, and agricultural pollution. Typhoid antibody testing plays a critical role in the early detection, confirmation, and monitoring of treatment effectiveness for typhoid fever. It also helps identify carriers and supports the implementation of preventive measures, crucial for managing and controlling waterborne diseases. For example, according to the Coalition against Typhoid, a US-based organization focused on preventing typhoid and other invasive salmonellosis, the Philippines reported 7,681 cases of typhoid (a waterborne disease) from January to August 2022, marking a 109% increase compared to the same period in the previous year. Hence, the escalation of waterborne diseases is a key driver behind the growth of the typhoid antibody testing market.

Leading companies in the typhoid antibody testing market are actively innovating to introduce advanced products such as molecular diagnostic tests, aiming to improve the precision and speed of diagnosing typhoid fever. Molecular diagnostic tests are renowned for their exceptional sensitivity and specificity, enabling swift and precise detection of pathogens such as Salmonella Typhi in cases of typhoid fever. For instance, Vanguard Diagnostics, a diagnostic reagent developer based in India, introduced the VANSCAN Typhoid RT PCR test in April 2023. This molecular diagnostic test utilizes proprietary technology to detect and diagnose typhoid fever through real-time PCR (RT-PCR) methodology, known for its enhanced accuracy and sensitivity compared to conventional serological tests. The launch of the VANSCAN Typhoid RT PCR Test represents a significant advancement in typhoid diagnostics, setting a new benchmark for early, precise, and dependable disease detection in India and globally.

In May 2022, Vanguard Diagnostics, an Indian company specializing in diagnostic solutions, including rapid card tests for detecting typhoid, forged a partnership with Graphic Era University. This collaboration capitalizes on Vanguard Diagnostics' technical proficiency to develop and introduce India's inaugural Typhoid RT-PCR test, renowned for its exceptional accuracy in diagnosis. The alliance with Graphic Era University, a prominent technological institute in India, aims to advance the diagnosis and treatment of this serious infectious disease.

Major companies operating in the typhoid antibody testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Sekisui Diagnostics, CTK Biotech Inc., Creative Diagnostics, Fortress Diagnostics Ltd., CerTest Biotec S.L, InBios International Inc., J. Mitra & Co. Pvt. Ltd, The Native Antigen Company, AroCell, AccuBioTech Co. Ltd, Vanguard Diagnostics private limited., Atlas Medical, Suburban Diagnostics India Private Limited, Biorex Diagnostics, Genebio Healthcare Private Limited, ICT Diagnostics.

Asia-Pacific was the largest region in the typhoid antibody testing market in 2023. The regions covered in the typhoid antibody testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the typhoid antibody testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Typhoid antibody testing is a diagnostic procedure aimed at identifying antibodies against Salmonella enterica serotype Typhi, the bacterium responsible for causing typhoid fever. The primary goal of typhoid antibody testing is to diagnose typhoid fever by detecting the immune response (antibodies) specific to Salmonella Typhi. This diagnostic tool facilitates timely and accurate diagnosis, enabling appropriate treatment and management of the disease.

Key products in the typhoid antibody testing market include rapid serological tests, hemagglutination and co-agglutination assays, counter immunoelectrophoresis, typhidot test, and widal test. Rapid serological tests are utilized to swiftly detect antibodies or antigens in a patient's blood sample. These tests are applicable to various serotypes of Salmonella, including paratyphi A, paratyphi B, and paratyphi C. End-users of these diagnostic tools include hospitals, serological testing centers, clinics, diagnostic laboratories, and other healthcare facilities.

The typhoid antibody testing market research report is one of a series of new reports that provides typhoid antibody testing market statistics, including the typhoid antibody testing industry global market size, regional shares, competitors with typhoid antibody testing market share, detailed typhoid antibody testing market segments, market trends, and opportunities, and any further data you may need to thrive in the typhoid antibody testing industry. These typhoid antibody testing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The typhoid antibody testing market consists of sales of immunochromatographic tests, western blot, and typhoid test strips. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.